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The number of American adults 65 years and older is projected to more than double by 2060, eventually making up 24% of the US population.1 This demographic shift has implications for clinical care as well as public health research and response. As the population ages, it will be imperative to find ways to preserve function and quality of life for these older adults to keep them independent in their communities for as long as possible. Preventing disability is of particular importance in preserving functional independence among the elderly, and has become the focus of much public health research.2 Clinicians must be able to identify and intervene on adults at risk of functional disablement in this growing population. 
To many older adults, fatigue is a primary source of functional limitation. It is the most commonly reported reason for restricted function among community dwelling older adults, and is often reported as a cause of disability among older women.3,4 Fatigue has been shown to have important, long lasting implications for subsequent function in older adults, and is a predictor of disability onset among the elderly.

1.2	Definition, Measurement and Prevalence of Fatigue in Older Adults
Fatigue as a concept is quite ambiguous, encompassing a reaction to physical and psychological effort, global exhaustion, need for sleep, lack of vitality, and a physiological reaction to heavy work load. Although definitions vary, fatigue in the context of aging populations can be defined as, “a subjective unpleasant symptom which incorporates total body feeling ranging from tiredness to exhaustion, creating an unrelenting overall condition which interferes with individuals’ ability to function to their normal capacity.”5 Fatigue can be distinguished from the concept of weakness in that fatigue typically implies a voluntary aspect, whereas weakness does not. Tiredness, which is considered normal at some times of the day and can be relieved with rest and sleep, is also distinct from fatigue.6
Many established, validated fatigue measures exist, but there is no ‘gold standard’ for measurement of fatigue. Most rely on self-report of specific symptoms or sensations associated with fatigue. Some aim to identify fatigue in specific medical populations (e.g. cancer patients), and some are appropriate for use within the general population. The established fatigue scales vary widely with respect to what exactly they’re measuring: some intend to capture severity, others impact on activities or lifestyle, and still others phenomenology.7 The wide variety in methods of capturing fatigue may contribute to heterogeneous or even contradictory results in the literature.
Fatigue has numerous consequences for the aging population. It has been associated with subsequent decline in physical function, mobility disability onset, functional limitation, risk of hospitalization, mortality, and onset of infections. ADDIN EN.CITE 6,8 Estimates of fatigue in both the general population and among older adults vary widely. Reported prevalence among adults 65 years and older has been as low as 8% and as high as 68%, with many studies reporting prevalence somewhere in between. ADDIN EN.CITE 9-11 The wide variation in findings can likely be attributed to factors like the lack of a gold standard measurement, varying cutpoints, choice of exposure time (e.g. fatigue in the present, last week, last month, etc.), and difference in the study populations.
The relationship between age and fatigue is unclear. A large US cohort, ages 51 and above, identified a “J-shaped” relationship between fatigue and age, with lowest fatigue at age 60-64 and increasing thereafter, and this relationship has been replicated in German cohorts. ADDIN EN.CITE 12-14 Paradoxically, other research appears to show to an inverse relationship between age and prevalence of fatigue, often with fatigue peaking during middle age (30-45 years), and then steadily declining to reach its lowest point among the oldest age groups (90+).  ADDIN EN.CITE 11,15-20 One potential explanation for this unanticipated direction of association is that global perceived measures of fatigue are prone to self-pacing bias, and subsequently less meaningful. ADDIN EN.CITE 9,21 As individuals age, they tend to titrate their activity level in order to maintain a bearable level of fatigue throughout the day. Because global fatigue is not anchored to a given demand or activity, and because of this activity titration, it is possible that a completely sedentary adult and an independent, active adult may report the same level of fatigue.9 Measuring fatigue may be less sensitive, and, as a result, important clinical implications may be missed when using this measure as an outcome or predictor. This may be one reason why younger individuals often report higher fatigue – they are more active than their older, retired counterparts. Fatigue, especially in older adults, describes the perceived fatigue state, but says very little about function.
Fatigue, as a concept decontextualized from daily activities and lifestyle, may not be accurately capturing symptoms and impact. This is especially true for older populations, who often report lower physical activity levels than their younger counterparts. Fatigability, as discussed below, may be able to overcome this limitation and better pinpoint older adults at risk for loss of function and mobility decline.
1.3	Definition, Measurement and Prevalence of Fatigability in Older Adults
Fatigability is defined as the relationship between fatigue and the level of activity (i.e., demand) with which fatigue is associated. Fatigability measures how susceptible an individual is to becoming fatigued, or a person’s tendency to grow tired. This is accomplished by anchoring measures of fatigue to standardized physical tasks and cognitive activities at fixed intensity, and, thus, allows for a more focused, objective, less-general measure of limitation due to fatigue. Measuring in this way can prevent self-pacing, can account for activity titration, a problem frequently encountered with older adults, and leads to more meaningful comparisons between participants and studies.9 Fatigability studies can be particularly useful for identifying functional areas in which fatigue limits participants’ activity. 
Fatigability is a relatively new concept, and as such, little is known about its epidemiology. Theoretically, fatigability is a more accurate, less biased measure of fatigue, and as such, should have similar, if not stronger, relationships with correlates and aging outcomes. Initial research seems to reflect this: slow gait speed, an established predictor of aging outcomes like mobility limitation, disability, hospitalizations, and mortality, has been associated with increased fatigability in adults aged 70-89 years. ADDIN EN.CITE 22 Fatigability has also been identified as a predictor of meaningful functional decline in older adults.23  
Fatigability is measured as either perceived fatigability or performance fatigability. Performance fatigability involves evaluating deterioration during a certain task, like slowing gait speed during a 400 meter or 6-minute walk test. ADDIN EN.CITE 21,24 Performance deterioration over the course of the task is then used to quantify fatigability. Perceived fatigability measures an individual’s self-reported feeling of tiredness as a function of the duration and intensity of an activity, and can be measured in two ways: by asking participants about their perceived exertion immediately following completion of a demand task, like a 6-minute walk test or 5-minute treadmill test, or by using the Pittsburgh Fatigability Scale (PFS), which characterizes both physical and mental fatigability. ADDIN EN.CITE 21,25,26 
The PFS asks participants to rate the level of physical and mental fatigue they say they experience or imagine they would experience, after completing a set of activities across a range of duration and intensity. ADDIN EN.CITE 25 The physical fatigability subscale was validated against both perceived exertion and performance deterioration measures in a cross-sectional study of adults aged 60 years and older (N=400), and showed strong internal consistency (Cronbach’s alpha 0.88) and excellent test-retest reliability (intraclass correlation 0.86). ADDIN EN.CITE 25
1.4	 Fatigability, Fatigue and Demographics
The Jerusalem Longitudinal Cohort Study [N=2480] examined fatigue in Israeli older adults at age 70, age 78, and again at age 85 using the question, “Do you feel generally tired?” Female sex was significantly associated with fatigue at age 70 (p0.05), age 78 (p0.0001), and age 85 (p0.0001). Prevalence of self-reported fatigue increased with age in this cohort, from 29% at age 70 to 68% at age 85. Being married was significantly associated with fatigue at only age 70 (p0.05) and age 85 (p0.005), but not age 78. At least 12 years of education was significantly associated with fatigue at age 78 (p0.0001) and age 85 (p0.0001), but had no association with fatigue at the youngest age. Current smoking was not significantly associated with fatigue at any of the three evaluated time points. Poor self-rated health was also significantly associated with fatigue at all three time points (p0.0001 for all). ADDIN EN.CITE 27 
The InCHIANTI Study [N=1055] conducted a cross-sectional analysis of fatigue and its correlates in a cohort of Italian adults aged 65 and older (mean age of 74.5 years). Participants were classified as fatigued if they self-reported 3 days over the past week in which they felt “that everything I did was an effort” or “I could not get going.” Analyses were stratified by sex. Smoking status was significantly associated with fatigue among women (p<0.01), but not among men. Self-rated health that was poor or very poor was significantly associated with fatigue in both men (p<0.01) and women (p<0.01). Older age was significantly associated with fatigue only among men (p<0.01), and having at least 6 years of education was not associated with fatigue in either sex. ADDIN EN.CITE 28
A study of a new fatigue measure, the PROMIS fatigue bank, was conducted in a US cohort of adults aged 18 to 75+ [N=666]. Fatigue was measured using the new instrument along with two established fatigue measures, the Functional Assessment of Chronic Illness Therapy Fatigue scale (FACIT-F) and the Short Form Health Survey (SF-36) Vitality subscale. Married participants reported significantly less fatigue than non-married adults on all fatigue measures (p<0.01). Participants with an advanced degree had significantly lower fatigue than those with some college education (p<0.05) or high school education (p<0.0001). Age in this cohort had a significant, weakly negative correlation with all fatigue scales, with the strongest correlation seen in the Vitality scale (r = -0.18, p<0.0001). Participants aged 30-44 reported higher fatigue when compared to the adults aged 60 years and older (p<0.05). ADDIN EN.CITE 19
The Northern Sweden MONICA study, which evaluated a large cohort [N=1557] aged 25-74 years of age, measured fatigue using the Multidimensional Fatigue Inventory (MFI-20) questionnaire. This questionnaire contains five fatigue subscales: general fatigue, physical fatigue, reduced activity, reduced motivation, and mental fatigue. General fatigue was significantly negatively correlated with age in this cohort (=-0.065, p<0.001), and this relationship was similar in both sexes. After adjustment for age, lower general fatigue and physical fatigue scores were significantly associated with having a university education for men (p<0.05), and lower physical fatigue scores were significantly associated with a university education in women (p<0.05). For both sexes, better self-rated health was significantly associated with lower fatigue scores for all subscales (p<0.001) after adjustment for age, sex, and socioeconomic status. ADDIN EN.CITE 20
Among studies in which information on gender was included, women consistently reported both higher rates and greater severity of fatigue than men. ADDIN EN.CITE 19,20,28-31
1.5	Fatigability, Fatigue, and Comorbidities
Diabetes is a likely cause of fatigability because of the alterations in blood glucose levels that the disease causes. Fluctuations in plasma glucose levels cause oxidative stress, which in turn has been associated with fatigue symptoms. ADDIN EN.CITE 32,33 A Danish cross-sectional study of newly diagnosed type II diabetics [N=1137] revealed that 61% of the cohort was presently experiencing fatigue, and fatigue was significantly associated with higher fasting plasma glucose levels. ADDIN EN.CITE 34  Fatigue has been a reoccurring complaint in studies of quality of life among type II diabetics.35 
Fatigue is a very common symptom of cancer patients, and estimates of its prevalence in this population range from 59% to nearly 100%.36 Fatigue often continues to be a problem after disease, and is the most prevalent symptom for survivors of cancer.37 Cancer related fatigue appears to be the result of a combination of genetic, inflammatory, and metabolic causes. ADDIN EN.CITE 38 A recent analysis of fatigability and cancer in the Baltimore Longitudinal Study of Aging [N=1665] found that high perceived fatigability (Borg RPE score 10) after a 5-minute treadmill test was significantly associated with history of cancer in adults 65 years of age (OR = 3.8, 95% CI 2.6-14.4).39 Perceived fatigability as a continuous measure, however, showed no relationship.
Symptoms of fatigue and depression often overlap. In fact, the relationship between fatigue and depression may be reciprocal: fatigue can be a result of clinical depression, and depression can be caused by chronic fatigue. ADDIN EN.CITE 40 In a Nordic cohort [N=561] where fatigue was assessed with the Mobility Tiredness scale and depressive symptoms with the Center for Epidemiologic Studies Depression Scale (CES-D), mean CES-D score and proportion reporting depressed mood (CES-D 16) were significantly associated with both fatigability and general fatigue (p<0.001 for all). ADDIN EN.CITE 30 
The Health Aging and Body Composition Study [N=1803] (mean age of 75.5 years) examined muscle fatigability using performance deterioration over the course of 30 muscular contractions, and depressive symptoms with the CES-D. Higher CES-D score was significantly associated with greater muscle fatigability (p<0.001) in this cohort, but fatigability was not predictive of depression at future follow up. ADDIN EN.CITE 41
A study of ambulatory older adults in a residential care facility [N=199] assessed fatigue with the modified Piper Fatigue Scale, and depression using the Yesavage Geriatric Depression Scale (GDS). Fatigue in this cohort had a significant, moderately strong correlation (correlation coefficient=0.568, p<0.0005) with GDS score in this cohort.10
The Jerusalem Longitudinal Cohort Study included analysis of several comorbidities. Depression, hypertension, and ischemic heart disease were significantly associated with fatigue at ages 70, 80, and 85 years (p0.005 for all), while diabetes was significantly associated with fatigue only at age 70 (p0.05). ADDIN EN.CITE 27 
Conversely, the InCHIANTI study found no association between diabetes, cancer, or hypertension and fatigue. Coronary heart disease, however, was significantly associated with fatigue in men (p<0.01), but not women. Number of comorbid conditions was also significantly associated with fatigue in men (p=0.02). CES-D score was significantly associated with fatigue in both men and women (p<0.01 for both). ADDIN EN.CITE 28 
1.6	Fatigability, Fatigue and Physical Function in Older Adults
Physical function is an important outcome in aging cohorts, as it relates to disability, ability to independently complete independent activities of daily living, comorbidities, and even mortality. ADDIN EN.CITE 27 A variety of measures of physical function are used in older adults, including grip strength, chair stands, gait speed, walk tests, the Short Physical Performance Battery (SPPB), the Instrumental Activities of Daily Living (IADL) assessment, and the Activities of Daily Living (ADL) assessment. Physical function has been examined with both fatigue and fatigability.  
Glynn et al. (2015) [N=483] examined the relationship between physical fatigability and physical performance as part of the validation of the Pittsburgh Fatigability Scale. Physical fatigability was significantly associated with slow gait speed and time to complete chair stands after adjustment for age, sex, and race (p<0.001). ADDIN EN.CITE 25 
The association between fatigue, fatigability, and gait speed was similarly assessed in a cross-sectional study of adults aged 70-89 years [N=36]. Fatigability was measured using both the Situational Fatigue Scale and the Borg scale after 400 m and 5-minute walking tests. Fatigability was again significantly associated with slow gait speed (p=0.042), but no associations with fatigue were found. ADDIN EN.CITE 22
A prospective study of fatigue and risk of IADL impairment was conducted over 10 years in adults aged 40-79 at baseline [N=534]. Fatigue was measured by asking males “Did you feel tired within the past 4 weeks?” and asking females “Do you feel tired?” IADLs were assessed at baseline and at follow up after 10 years. Mobility was also measured using a 6-minute walk test. Males reporting fatigue were significantly more likely to have IADL limitations (OR = 3.29, 95% CI 1.95-5.55), but this relationship was weaker and nonsignificant among females. Fatigued males also walked a significantly shorter distance during the walk test than non-fatigued males (p=0.048), but this relationship was weaker and non-significant among females. ADDIN EN.CITE 29
In the InCHIANTI cohort previously described, physical function was measured using grip strength, the SPPB, and gait speed during a 400-m walking test. Disability was classified using the ADL and IADL. After adjustment for age, smoking, and sedentary activity, both fatigued men and fatigued women had weaker grip strength, lower SPPB score, slower gait speed, and ADL and IADL disability than non-fatigued men and women. Gait speed, SPPB score, and IADL disability remained significantly associated with fatigue in both sexes after further adjustment for several comorbidities, inflammatory markers, and health behaviors. The relationships varied significantly between men and women: the strongest relationship in women was between fatigue and ADL disability (OR=5.14, 95% CI 1.86-14.21) in the fully adjusted model, and the strongest relationship in men between fatigue and SPPB in the fully adjusted model ( coefficient = -1.05, p=0.001). ADDIN EN.CITE 28
In the Jerusalem Longitudinal Cohort Study, fatigue was significantly associated with reported difficulty with ADL’s and with reported ADL dependence at all three time points. The difference in ADL dependence for fatigued vs. non-fatigued adults widened with increasing age: 4% vs. 9% at age 70 (p0.05) to 18% vs. 47% reporting ADL dependence at age 85 (p0.0001). Fatigue reported at age 70 was a significant predictor of future ADL difficulty after adjustment for several demographic variables and comorbidities (OR=2.9, 95% CI 1.4-6.1) ADDIN EN.CITE 27 
Previous cross-sectional research shows that fatigue and fatigability are related to several markers of physical function, particularly gait speed and IADL. In at least one study, fatigability appears to have a stronger relationship with physical function than fatigue, which corroborates the theory that fatigability is a stronger, less biased measure. ADDIN EN.CITE 22 Fatigability appears to be an important correlate, or even predictor, of physical function in older adults.
1.7	Fatigability, Fatigue and Cognition
There is a paucity of research that examines the relationship between cognitive status and fatigue, but a few cohorts included cognition as a potential correlate.
The Jerusalem Longitudinal Cohort Study looked at cognition and fatigue using the Mini Mental Status Examination (MMSE). Fatigue was associated with both mean MMSE score (p0.0001) and low MMSE score (p0.0001) only at age 85. No association between cognition and fatigue was found at age 70 or 78. ADDIN EN.CITE 27 MMSE score in the InCHIANTI Study Cohort was not significantly related with fatigue in men or women. ADDIN EN.CITE 28
In the previously described cohort of ambulatory older adults, mental status as measured by the MMSE had no correlation with modified Piper Fatigue Scale.10 
1.8	Fatigability, Anthropometrics and Physical Activity in Older Adults
There is growing evidence to suggest that body composition may have a causal relationship with fatigue. The excessive body fat seen with obesity could, in fact, cause inflammation, therefore increasing the risk of fatigue symptoms. ADDIN EN.CITE 42,43 Beyond the potential inflammatory response, fatigue is increased by obesity through higher prevalence of sleep problems, physical and psychiatric comorbidities, and other metabolic processes. ADDIN EN.CITE 44
The relationship between fatigue and physical activity is likely reciprocal. As older adults experience more fatigue, they likely lessen their activity in order to keep their fatigue within a comfortable window. Decreased physical activity, however, is an established risk factor for future disability and loss of function, and may therefore lead to future fatigue. ADDIN EN.CITE 45
An evaluation of both perceived and performance fatigability measures in older adults (mean age of 85) [N=43] identified a significant, moderately strong negative correlation between physical activity level and fatigability severity using both perceived and performance measures (r= -0.42 and -0.44, respectively, p=-0.02).24
In the Jerusalem Longitudinal Study Cohort, physical activity was measured using a self-report questionnaire with low physical activity classified as less than four hours of physical activity per week. Self-reported low physical activity was significantly associated with fatigue at age 70 (p0.05), age 78 (p0.0001), and age 85 (p0.0001). Fatigue at age 70 was a significant predictor of low physical activity at future follow up after adjustment for demographics and comorbidities (OR = 5.1, 95% CI 1.9-13.4). BMI in this cohort was not significantly associated with fatigue at any age.  ADDIN EN.CITE 27
BMI in the previously described InCHIANTI cohort was not significantly associated with fatigue in men or women. ADDIN EN.CITE 28
In the northern Sweden MONICA study, physical activity was measured using the Cambridge Physical Activity Index. Higher reported physical activity was significantly associated with both lower general fatigue and lower physical fatigue (p<0.0001) after adjustment for age, sex, and socioeconomic status. ADDIN EN.CITE 20
Physical activity in the Baltimore Longitudinal Study of Aging, which included adults aged 59-97 [N=557], was measured using accelerometers worn by participants for 7 consecutive days. Fatigability in this cohort was measured using perceived exertion after a 5-minute treadmill test as measured by the Borg scale. Perceived fatigability was significantly associated with decreased daily physical activity after adjustment for demographic, medical, and behavioral variables (p=0.01). ADDIN EN.CITE 46
1.9	 Heritability of Fatigability and Fatigue
The genetic basis of fatigability has yet to be studied, but research into heritability of fatigue may give some insights.
A sibling study conducted in the United Kingdom [N=10444] assessed fatigue using a five-item scale of their own design. Participants were asked questions such as “have you recently been having problems with tiredness?” and responded on a scale from “not at all” to “much more than usual.”  Analysis of the sibling correlation for fatigue resulted in a heritability estimate of 18-22% in this cohort. ADDIN EN.CITE 31 
A twin study of female-female twin pairs [N=146] examined three types of chronic fatigue: fatigue experienced for at least 6 months, medically unexplained chronic fatigue, and idiopathic chronic fatigue, with the last type having the most stringent definition. Heritability estimates for chronic fatigue in this cohort ranged from 30% for chronic fatigue for past 6 months, up to 65% for idiopathic chronic fatigue. ADDIN EN.CITE 47
A US-based twin study [N=1870] using similar fatigue classifications found a difference in heritability by sex. Males had a much higher heritability of prolonged fatigue than females (51% versus 18%, respectively). Results for females indicated most of the variance in fatigue was due to environmental effects, but a significant portion of the variance in males was due to genetics. ADDIN EN.CITE 48
Recently, a large cohort in the United Kingdom [N=108976] was used to evaluate genetic contributions to fatigue. Participants were asked “Over the last two weeks, how often have you felt tired or had little energy?” and responses were categorized into four groups, ranging from ‘not at all’ to ‘nearly every day’. GWAS identified three potential SNPs on chromosomes 1 and 17. Gene-based association analysis highlighted five genes that attained genome-wide significance for fatigue: DRD2, which encodes a dopamine receptor; PRRC2C, which has been associated with lung cancer; ANO10, which causes cerebellar ataxias; ASXL3, which is associated with intellectual disability, and C3orf84, of which very little is known. Common SNPs were found to explain only 8.4% of the variation in fatigue in this cohort. Gene-based heritability in this cohort was similar in both sexes: 9.4% in females and 8.2% in males. The authors did point out that among males, heritability differed by age, with heritability decreasing as age increases. ADDIN EN.CITE 49
Across the literature, genetic heritability estimates vary widely, likely due to extremely heterogeneous populations and differing measures of fatigue. Despite the large range in heritability estimates, all studies report some degree of genetic influence on fatigue.
1.10	Gaps in Knowledge
Fatigability, as a relatively new concept, has not fully been examined in the context of aging populations. Some research has been done into the relationships between fatigability and physical function and activity, but little is known about its genetic basis or the relationships between fatigability and comorbidities, demographics, cognitive function, and anthropometrics. Replicating and expanding the research into fatigability, physical function and activity is vital to fully understanding the associations, and other correlates of fatigability must still be identified. 
Research on fatigability is particularly important as the US population ages. Although age does not seem to have a clear relationship with fatigue, researchers have hypothesized that fatigability, due to its adjustment for the self-pacing that is common in older adults, will have stronger association with aging.50 Fatigability may determine functional status in older adults by limiting activity to maintain a tolerable level of fatigue, thus leading to increased sedentary behavior.50 In order to prevent this decline in activity and function, both pharmacological and nonpharmacological interventions must be developed. Identifying modifiable and non-modifiable correlates of fatigability in an older population will assist in the future development of these targeted interventions.
1.11	Public Health Significance
Fatigue is a highly prevalent symptom in the aging population. Estimates of fatigue in American adults are as high as 37.9%, and prevalence in the UK has been reported as high as 52.8%. ADDIN EN.CITE 49,51 Fatigue can be highly limiting for older adults, and have a significant impact on quality of life.52 In a primary care setting, fatigue is one of the most common complaints, appearing in up to 20% of all patient presentations. ADDIN EN.CITE 53,54  Beyond the limitation and unpleasant nature of fatigue, several cohort studies have revealed a significant association between high levels of fatigue and mortality in adults. ADDIN EN.CITE 27,55,56 
Fatigue has been established as an important risk factor for loss of function, disability, future disease, and mortality. However, as researchers realize that traditional fatigue measurements are likely inadequate due to differences in physical activity and self-pacing among the elderly, it becomes more important to reexamine these relationships with stronger measures, such as fatigability. Analysis of the correlates of fatigability in this cohort of older adults will help researchers and clinicians better identify those at high risk of fatigability, and therefore those at risk for poor aging outcomes.
2.0 	OBJECTIVE
The objective of this research is to identify potential correlates and to estimate genetic heritability of physical fatigability, measured with the Pittsburgh Fatigability Scale, in adults age 60 years and older from the Long Life Family Study (LLFS).

3.0 	METHODS
3.1	 The Long Life Family Study 
The Long Life Family Study is a cohort study of families determined to have ‘exceptional survival’ by the Family Longevity Selection Score (FLoSS), described in detail below. Probands with exceptional survival were enrolled along with their siblings (n=1445), their offspring (n=2329), and spousal controls (n = 785) for a total sample size of 4559 participants. American field centers used lists of Medicare enrollees from the Center for Medicare and Medicaid Services to target older adults with mailed recruitment brochures. The University of Southern Denmark field center identified potential participants through the Danish National Register of Persons. Danish parish registers were additionally used to locate siblings.
Potential probands were screened for eligibility by telephone. Eligibility for the study was determined using the Family Longevity Selection Score (FLoSS). FLoSS scores were determined using U.S. Census Bureau gender-stratified birth-cohort survival probabilities combined with information about the current age or age at death of siblings, and the number of family members still alive for potential inclusion in the study.57 A FLoSS score of 7 or higher met the pre-screening eligibility criteria.
If the proband’s family was FLoSS eligible, met the minimum family size of 3 (the proband, at least one living sibling, and at least one living offspring), and was able and willing to consent and participate in the interview, examination, and blood draw, the family was included in the cohort. Probands were asked to contact other family members about potential enrollment, and informed consent was obtained from all participants. In the case of cognitive impairment, informed consent was obtained via proxy.
Baseline interviews and examinations were conducted in the participants’ homes by trained research assistants using a common protocol between 2006 and 2009. Participants were then followed up with on a yearly basis with a telephone interview. A second round of interviews and examinations in the home were conducted from 2014-2017. Data included in these analyses were obtained during the second home visit of the study. If an in-person visit was not possible, interview was conducted over the phone and a blood or saliva sample was obtained by an outside physician’s office or laboratory. ADDIN EN.CITE 58
3.2	Fatigability Measure
Physical fatigability in the LLFS was measured using the 10-item Pittsburgh Fatigability Scale (PFS). The PFS evaluates both mental and physical fatigability, however, this essay focuses only on the physical fatigability subscale. The PFS was self-administered. 
Participants were asked to rate the experienced or imagined physical fatigue the would feel immediately following an established length and duration of a certain activity, for example, a leisurely walk for 30 minutes. Fatigue was reported on a scale from 0 (no fatigue) to 5 (extreme fatigue), and the self-reported fatigue score for each of the 10 items was summed up to achieve the final physical fatigability score. PFS physical scores range from 0-50, with higher score indicating greater physical fatigability. ADDIN EN.CITE 25
A cutpoint for higher physical fatigability was established during the validation of the PFS by deriving the midpoint values (mean adjusted high PFS fatigability score – half of the adjusted mean difference) when comparing high versus low fatigability for several non-PFS fatigability and performance measures used in the validation study. ADDIN EN.CITE 25 This established cutpoint (PFS physical score 15) was used to categorize higher vs. lower fatigability in this cohort.
3.3	Other Data Sources
Date of birth was validated using an official document or source such as a driver’s license or birth certificate. Sex, race, ethnicity, and education levels were self-reported. History of hypertension, cancer, and diabetes were ascertained with self-report of a physician diagnosis and date of onset. Cancer history in this analysis excluded diagnoses of skin cancer. Standing height and weight were measured at the home visits by the interviewers. Sitting blood pressure was measured using the average of three readings from an automated blood pressure machine. Physical function was measured with questions about difficulty in ADL’s and IADL’s as well as the Short Physical Performance Batter (SPPB). ADL difficulty was defined as having difficulty with at least one of the following three items: bathing/showering, walking up 10 steps, and getting in/out of a bed or chair. SPPB is an objective assessment of lower extremity function in older adults, involving balance tests, walking tests, and chair stands, and was administered in the home by trained interviewers. ADDIN EN.CITE 59 Gait speed was measured using the timed walk test administered within the SPPB, and grip strength was assessed with an isometric dynamometer in a seated position to the nearest 2 kg. Cognition was assessed using the MMSE and the Digit Symbol Substitution Test (DSST). Blood glucose was measured after a fast of at least 6 hours and analyzed by the LLFS central laboratory at the University of Minnesota. ADDIN EN.CITE 58
Physical activity levels were assessed using the Framingham Physical Activity Index.60
3.4	Statistical Analyses
Two thousand, seven hundred and forty-six members of the original cohort completed the second home visit, and 160 new family members were recruited for a total of 2,906 participants with data from Visit 2. Participants younger than 60 years of age were excluded (N=306). Of the remaining 2603 participants, 3 had no information on age, and 242 had no physical PFS data, resulting in a final sample of 2355 participants, including 137 with incomplete PFS data who had scores imputed. 
If 3 items in the physical PFS were missing, but a related question on whether the activity had been done in the past month was answered, a value for the missing response was imputed based on the mean value of an individual’s valid responses and adjusted for varying intensity levels of different activities and differences in the levels of fatigue reported by study members who had and had not done each specified activity.61 
The relationship between potential risk factors and higher versus lower fatigability was examined overall, and stratified into four age groups: 60-69, 70-79, 80-89, and 90+ years. The relationship between mean PFS score and age category was adjusted for field center (Boston, Pittsburgh, New York City, or Denmark), family structure and sex. The relationships between continuous variables and higher vs. lower fatigability were evaluated using T-tests. Categorical variables were analyzed using chi-squared tests where appropriate, or Fisher’s exact tests where the expected cell count fell below 5.
Heritability of fatigability was examined using the variance component framework implemented in the Sequential Oligogenic Linkage Analysis Routines (SOLAR) program, which estimates the effect of additive genetics adjusted for family structure. ADDIN EN.CITE 62,63 Additionally, we adjusted genetic heritability analyses for age, sex, and field center.

4.0 	RESULTS
Table 1 presents the overall characteristics of the cohort, which was 55% female and had a mean age of 74.5 years. Participants overall were overweight, highly educated, and did not currently smoke. When stratified by higher vs. lower fatigability, only smoking status was not significantly associated with physical fatigability. All comorbidities, markers of physical and cognitive function, physical activity, and other demographic variables had strong relationships with fatigability (p<0.0001 for all). 
Table 2 presents the relationship between higher vs. lower fatigability and age categories. The prevalence of higher fatigability rose significantly in the older age groups, from 27.9% in the 60-69 age group to 89.5% highly fatigable participants aged 90+ (p<.0001). The mean physical PFS score followed this trend, increasing from 11.0 in the youngest group up to 28.6 in the oldest category. This relationship between mean PFS score and age group was significant even after adjustment for sex, family structure, and field center (p<0.0001).
When further stratified by gender, as shown in Figure 2 and Figure 3, the relationship between fatigability and age remains similar. Females reported both higher mean PFS scores and a larger proportion with high fatigability than males in each age group. The relationship between sex and proportion with higher fatigability was significant in every age group. Females had significantly higher PFS scores at ages 60-69 (p=0.0014), 80-89 (p=0.0005), and 90+ (p=0.0019), and the difference was close to significant at age 70-79 (p=0.0532). The greatest sex difference in PFS scores can be seen in the 80-89 age category, where females scored 21.1 on average, and males scored 17.3. The sex difference in proportion with higher fatigability is also largest within the 80-89 age category, where 74.8% of females have a score 15 versus 53.5% of males. 
Table 3 presents the potential correlates of higher vs. lower fatigability. Being currently married was significantly associated with lower fatigability only at age 60-69 and 80-89, although a similar association was nearly significant in age ranges 70-79 and 90+. Lower education level was significantly associated with higher fatigability at age 70-79 and age 80-89, but was not related with fatigability in the oldest and youngest age groups. Fair or poor self-rated health was significantly associated with higher fatigability in the two youngest age groups (p0.0001). Smoking status was not associated with higher fatigability in any age category.
Mean CES-D score in this cohort was low overall, but those with higher fatigability had consistently higher CES-D scores in all age categories. The difference in depression symptom severity was largest in the 80-89 age category: 5.24.4 in the higher fatigability group versus 2.22.4 in the lower fatigability group. Self-reported diabetes was significantly associated with higher fatigability only in the two youngest age groups (p0.0001). Fasting glucose was associated with higher fatigability in the 60-69, 70-79, and 90+ age categories, with the largest difference in fasting glucose seen in the youngest age group. Self-reported hypertension was significantly associated with higher fatigability in age 60-69, 70-79, and 80-89, but was not associated with fatigability in the oldest age category. Although those with higher fatigability had higher cancer rates overall, no differences in cancer rates were found in the age stratified analysis.
With the exception of IADL difficulty, all measures of physical function (grip strength, SPPB, gait speed, and ADL difficulty) were significantly associated with higher fatigability in all age groups. SPPB score and ADL difficulty showed the strongest relationships, with p<0.0001 in every age group. Difference in SPPB score widened with age, from a 0.6 point difference in the youngest age group to a 3 point difference in the oldest. ADL difficulty had the largest difference in the 80-89 age category: 71.52% reporting difficulty in the higher fatigability group versus 16.09% in the lower fatigability group. IADL difficulty had no relationship with higher fatigability in the youngest age category. 
A lower mean MMSE score was significantly associated with higher fatigability in age groups 70-79 and 90+. Lower digit symbol substitution score was significantly associated with higher fatigability at age groups 60-69, 70-79, and 90+, and the relationship was strongest in the oldest age category. 
A higher BMI was significantly associated with higher fatigability in the two youngest age categories, but had no relationship with fatigability in the older age groups. Lower physical activity was significantly associated with higher fatigability in all age categories.
After adjustment for age, sex, and field center, the residual heritability of fatigability was 0.263 (p=6.6x10-9).
5.0 	Discussion
The results of this cross-sectional analysis of the Long Life Family Study cohort suggest that fatigability is significantly associated with increasing age, female sex, lower levels of physical activity, and several measures of physical function. 
Estimates of heritability in this cohort indicate that there is some genetic basis to fatigability in older adults. 26.3% of the variation in physical fatigability in this cohort can be attributed to additive genetic factors, indicating moderate heritability in this population. This is in agreement with the fatigue literature, which has estimated the heritability of fatigue between 18 and 51%. ADDIN EN.CITE 31,48 Several SNPs have been identified with potential association to fatigue, and future research into fatigability should include analysis of the genome to better understand the etiology of fatigability. ADDIN EN.CITE 49 Some fatigue research has identified a differing heritability based on age or sex, with potentially higher heritability in males and in younger ages. ADDIN EN.CITE 48,49 Future research should examine if the heritability of fatigability exhibits similar variation in these groups. 
Before stratification by age, fatigability is significantly associated with all potential risk factors except for smoking status. However, the overall sample is heavily weighed toward the younger participant: 1837 participants under 80 versus 518 above 80 years old. Therefore, it is likely that the stratified results are more meaningful.
The relationship between age and fatigability status in this cohort contradicts the results of several previous studies of fatigue, which have shown either an inverse or non-existent relationship. ADDIN EN.CITE 11,15-20 As discussed in the introduction, the use of fatigability instead of fatigue as a measure likely plays a role in our differing results. The disagreement in findings is consistent with the hypothesis that, due to the self-pacing that is common in older adults, measures of global fatigue may not be able to capture the relationship between age and the impact of fatigue.50 By using the PFS, which controls for that self-pacing, we’re able to see that as age increases, daily activities become less and less tolerable, consistent with research that identifies fatigue as a major functional limitation in older adults. ADDIN EN.CITE 3,4 
As expected, female sex was significantly associated with both fatigability status and higher PFS scores. This corroborates and extends the findings from several fatigue studies, which have identified higher prevalence and severity of fatigue in women. ADDIN EN.CITE 19,20,28-31 Several hypotheses exist to explain this sex difference, namely that endocrine, stress-related, and socio-contextual factors may account for this disparity. ADDIN EN.CITE 64,65 Further research is needed to fully understand the etiology of this increased risk in females.
All measures of physical function included in these analyses were significantly associated with fatigability status. SPPB, ADL difficulty, and gait speed had particularly strong relationships with fatigability across all age categories. Previous research has linked fatigability to gait speed and other objective measures of physical function, but ours is the first to identify ADL and IADL difficulty as significant predictors of fatigability status in older adults. Our findings corroborate the existing fatigability research, but more exploration is needed to determine whether fatigability leads to decline in physical function, or if loss of physical function contributes to higher fatigability.
Overall, higher fatigability was associated with higher cancer rates, but once stratified by age, cancer was not significantly associated with fatigability in any age group. This is an unexpected finding, as fatigue is a common complaint of both cancer patients and survivors, and these findings differ from the Baltimore Longitudinal Study’s evaluation of fatigability, which identified cancer history as a significant predictor.39 However, the InCHIANTI cohort had similar results with respect to fatigue and cancer. ADDIN EN.CITE 28 The lack of association found in the LLFS and the InCHIANTI could be because both used a representative population of older adults, rather than a cancer specific one, making it more difficult to see the exact effect of cancer on fatigue or fatigability. Another possible explanation for the lack of relationship with cancer is that we measured any history of cancer (excluding skin), similar to the InCHIANTI study, and incident cancer, rather than cancer history, may have a more direct relationship with fatigability, Future research should work to address this uncertainty. Finally, it is possible that cancer history might have a larger impact on mental fatigability than the physical fatigability that was assessed in these analyses. Including the mental fatigability subscale of the PFS in future research could help to clarify the broader relationship with cancer. 
Cognitive function appears to have some association with fatigability in this cohort, despite a lack of clear association in the previous literature. The MMSE had a significant relationship with fatigability in two age groups, and the digit symbol substitution test, designed to measure psychomotor speed, demonstrated a significant relationship to fatigability in three out of the four age groups. Psychomotor speed captures the relationship between physical movement and conscious cognitive processing, and has previously been associated with two established correlates of fatigability: gait speed and physical activity. ADDIN EN.CITE 66,67 Therefore, although the exact nature of this association is not yet fully understood, it’s likely that a relationship between physical fatigability and cognitive function exists.
Of the comorbidities examined, only depression was significantly associated with fatigability in all age groups. Diabetes was significantly or nearly significantly associated with fatigability in all age groups except for the 90+ participants, which consistent with previous fatigue research, in which diabetes was associated with fatigue in the younger participants. ADDIN EN.CITE 27,28,34,35 Similarly, hypertension was significantly with fatigability associated in every age group but the oldest, in agreement with the results of the Jerusalem Longitudinal Study cohort. ADDIN EN.CITE 27 Self-rated health and BMI demonstrated a similar trend: significance in the younger age groups, and no relationship in the older. 
Overall, the 80-89 and 90+ age groups yielded fewer significant relationships with fatigability status than the younger age groups. This may be indicative of a change in etiology of fatigability with aging – perhaps it becomes more idiopathic with age, and previously protective factors have a smaller effect – but it may also be a result of some of the study’s limitations. The 80-89 and 90+ age categories had much smaller sample sizes than either the 60-69 or 70-79 groups, with only 28 participants meeting the lower fatigability criteria in the oldest category. Additionally, bias due to a healthy survivor effect – meaning that the healthiest participants are the ones surviving to the oldest age group – may have an effect on our results in the 80+ year old participants. 
In addition to these limitations in the older age groups, a few general limitations of this study exist. First, these analyses are cross-sectional, so the causal direction of the relationships with fatigability status cannot be identified. Further, due to a paucity of fatigability research, we are limited in comparisons of our results mainly to studies of fatigue, so future work specifically focusing on fatigability must be done to confirm our results. Finally, the Long Life Family Study Cohort is made up almost entirely of white families, and is a cohort enriched for exceptional survival, so these results may not be widely generalizable. 
However, there are also many strengths of this study. Use of the PFS, a validated measure of fatigability, allowed us to reliably examine this novel concept in a cohort of older adults. The large sample size available in the LLFS is another strength, particularly in the younger age groups. Although many epidemiologic studies have been done on the correlates of fatigue in older adults, we are the first to present a cross-sectional analysis of the correlates of fatigability in this population.
































Figure 1. Analytic sample flow chart from full LLFS cohort


Table 1. Potential risk factors of perceived physical fatigability, overall and by fatigability status
	Overall [N=2355]*	PFS 15 [N=992]*	PFS <15 [N=1363]*	P-value
Age	74.511.0	78.612.3	70.07.0	<0.0001
Female sex	54.7	60.4	50.6%	<0.0001
Currently married	69.0 [1624]	55.8 [553]	78.6% [1071]	<0.0001
Education level:Less than high schoolHigh school or equivalentMore than high school	7.3 [172]8.4 [197]84.3 [1983]	9.1 [90]13.8 [137]77.1% [764]	6.0% [82]4.4% [60]89.6% [1219]	<0.0001
Smoking status:CurrentFormerNever	4.0 [93]39.0 [913]57.1 [1337]	3.11 [31]39.8 [392]57.1 [563]	4.6 [62]38.4 [521]57.0 [774]	0.2025
Fair or poor self-rated health	4.1 [97]	6.9[68]	2.13% [29]	<0.0001
Diabetes	9.9 [232]	13.5 [134]	7.19% [98]	<0.0001
Fasting glucose (mg/dL)	100.222.3  [2167]	103.027.7 [887]	98.317.3 [1280]	<0.0001
Hypertension	46.8 [1101]	58.9 [584]	37.9 [517]	<0.0001
Cancer	18.3 [43]	21.1 [209]	16.2 [221]	0.0026
Table 1. Potential risk factors of perceived physical fatigability, overall and by fatigability status, continued.
CES-D score1	3.33.5 [2271]	4.44.0 [938]	2.52.9 [1333]	<0.0001
Grip strength (kg)	29.211.3 [2239]	25.311.3 [929]	31.910.4 [1310]	<0.0001
SPPB score2	10.22.7 [2248]	8.83.3 [926]	11.11.5 [1322]	<0.0001
Gait speed (m/s)	1.00.3 [2193]	0.90.3 [909]	1.10.3 [1284]	<0.0001
ADL difficulty3	28.0 [660]	55.9% [554]	7.8 [106]	<0.0001
IADL difficulty4	20.1 [474]	32.8% [325]	10.9 [149]	<0.0001
MMSE score5	28.42.9 [2265]	27.63.9 [954]	29.01.5 [1311]	<0.0001
Digit symbol substitution score	44.513.6 [2168]	39.714.2 [880]	47.812.1 [1288]	<0.0001
Body Mass Index(kg/m2)	27.45.0 [2229]	28.35.8 [914]	26.84.3 [1315]	<0.0001
Total MET hours per day6	36.37.2 [2306]	33.46.5 [972]	38.56.9 [1334]	<0.0001

*Mean  SD [N] or % [N]
1. Centers for Epidemiologic Studies Depression Scale Score
2. Short Physical Performance Battery Score
3. Activities of Daily Living
4. Instrumental Activities of Daily Living
5. Mini Mental State Examination
6. Metabolic Equivalent of Task


Table 2. Perceived physical fatigability by age 
	60-69	70-79	80-89	90+
N	1000	837	252	266
Mean PFS1  SD* 	11.0  7.6	12.5  8.1	19.3  9.9	28.6  9.8**
N (%) High Fatigability 	279 (27.9%)	310 (37.0)	165 (65.5)	238 (89.5)**
*adjusted for field center, sex, and family structure
** p<0.0001 for trend across age groups











Figure 2. Mean perceived physical fatigability scores by age category, stratified by sex

Figure 3. Prevalence of high physical fatigability by age category, stratified by sex
Table 3. Potential risk factors and higher versus lower fatigability, stratified by age category
	60-69	70-79	80-89	90+
	PFS 15	PFS <15	PFS 15	PFS <15	PFS 15	PFS <15	PFS 15	PFS <15
Currently married	73.5 [205]*	0.0047**81.6 [588]	73.9 [229]	0.069379.3 [418]	52.1 [86]	0.041365.5 [57]	13.9 [33]	0.052828.6 [8]
Education level:Less than high schoolHigh school or equivalentMore than high school	2.9 [8]4.3 [12]92.8 [259]	0.34074.6 [33]3.2 [23]92.2 [664]	9.0 [28]9.4 [29]81.6 [253]	0.00356.7 [35]4.2 [22]89.2 [469]	6.7 [11]27.3 [45]66.1 [109]	0.024310.3 [9]12.6 [11]77.0 [67]	18.1 [43]21.5 [51]60.3 [143]	0.649217.9 [5]14.3 [4]67.9 [19]
Smoking status:CurrentFormerNever	4.7 [13]36.2 [100]59.1 [163]	0.95895.2 [37]36.2 [260]58.6 [421]	3.6 [11]49.4 [153]47.1 [146]	0.05334.4 [23]40.8 [214]54.9 [288]	2.5 [4]33.7 [55]63.8 [104]	0.44762.3 [2]41.9 [36]55.8 [48]	1.3 [3]35.4 [84]63.3 [150]	0.10890.0 [0]39.3 [11]60.7 [17]
Fair or poor self-rated health	6.8 [19]	<0.00011.9 [14]	8.4 [26]	<0.00011.9 [10]	3.0 [5]	1.0003.5 [3]	7.6 [18]	1.0007.1 [2]
Diabetes	11.1 [31]	0.00155.4 [39]	15.2 [47]	0.00779.1 [48]	17.0 [28]	0.05158.1[7]	11.8 [28]	0.757414.3 [4]
Table 3. Potential risk factors and higher versus lower fatigability, stratified by age category, continued.
Fasting glucose (mg/dL)	104.336.0 [257]	0.004097.616.0 [678] 	104.124.3 [285]	0.004499.319.5 [499] 	102.323.9 [152]	0.261799.415.0 [78] 	100.021.9 [193]	0.031693.711.7 [25]
Hypertension	44.4 [124]	<0.000129.7 [214]	60.0 [186]	<0.000145.4 [239]	70.3 [116]	0.010154.0 [47]	66.4 [158]	0.549560.7 [17]
Cancer	12.9 [36]	0.717912.1 [87]	25.2 [78]	0.101920.3 [107]	28.5 [47]	0.253921.8 [19]	20.2 [48]	0.302228.6 [8]
CES-D score1	4.13.8 [277]	<0.00012.53.0 [702] 	4.03.9 [304]	<0.00012.42.8 [520] 	5.24.4 [157]	<0.00012.22.4 [84] 	4.94.0 [200]	0.04033.23.3 [27] 
Grip strength (kg)	31.411.1 [267]	0.025733.110.6 [692] 	28.810.3 [295]	0.000331.510.0 [512] 	20.77.8 [156]	<0.000127.78.9 [80] 	16.16.9 [211]	0.002920.56.8 [26] 
SPPB score2	10.8 1.8 [267]	<0.000111.4  1.1 [699] 	10.32.0 [298]	<0.000111.11.4 [513] 	8.02.8 [151]	<0.000110.01.8 [83] 	4.82.9 [210]	<0.00017.83.3 [27] 
Gait speed (m/s)	1.00.2 [260]	<0.00011.10.2 [684] 	1.00.2 [291]	<0.00011.10.2 [496] 	0.80.2 [149]	0.00551.10.9 [77] 	0.60.2 [209]	<0.00010.80.2 [27] 
ADL difficulty3	29.8 [83]	<0.00014.7 [34]	41.9 [130]	<0.00018.0 [42]	71.5 [118]	<0.000116.1 [14]	93.7 [223]	<0.000157.1 [16]
IADL difficulty4	10.0 [28]	0.27877.9 [57]	20.3 [63]	0.000611.6 [61]	37.6 [62]	0.049125.3 [22]	72.3 [172]	<0.000132.1 [9]
MMSE score5	29.32.1 [270]	0.898229.21.5 [694] 	28.62.4 [305]	0.006429.01.3 [508] 	27.43.6 [158]	0.156127.91.9 [82] 	24.45.2 [221]	<0.000127.22.2 [27] 
Digit symbol substitution score	49.510.3 [266]	0.001752.011.4 [686] 	42.510.1) [294]	0.021844.310.4 [498] 	35.411.9 [143]	0.062438.612.7 [79] 	23.912.0 [177]	0.000732.610.6 [25] 
Table 3. Potential risk factors and higher versus lower fatigability, stratified by age category, continued.
BMI (kg/m2)	29.86.8 [267]	<0.000127.04.4 [693] 	29.25.4 [297]	<0.000126.64.3 [511] 	27.35.2 [149]	0.164326.53.9 [84] 	25.94.3 [201]	0.479526.32.7 [27] 
Total MET hours per day6	35.86.9 [276]	<0.000138.46.8 [709] 	35.35.9 [304]	<0.000138.96.9 [514] 	32.76.0 [162]	<0.000138.37.5 [84] 	28.54.1 [230]	0.000533.86.9 [27] 
*Mean  SD [N] or % [N]
** p-value
1. Centers for Epidemiologic Studies Depression Scale Score
2. Short Physical Performance Battery Score
3. Activities of Daily Living
4. Instrumental Activities of Daily Living
5. Mini Mental State Examination
6. Metabolic Equivalent of Tas
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